This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignee: Molecular Partners Ag. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2022
Title: The Innovative Journey of Ivo Sonderegger
Introduction
Ivo Sonderegger, a prominent inventor based in Urdorf, Switzerland, has made significant contributions to the field of biochemistry through his patents. He has a total of five patents to his name, illustrating his innovative spirit and dedication to advancing scientific knowledge.
Latest Patents
Sonderegger's latest patents focus on recombinant binding proteins and their applications. His innovations involve new designed ankyrin repeat domains that exhibit binding specificity for serum albumin. These patents describe recombinant binding proteins comprising at least two designed ankyrin repeat domains with this specificity, as well as proteins that bind to hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF-A). Furthermore, these patents include nucleic acids that encode such designed ankyrin repeat domains and recombinant binding proteins, along with associated pharmaceutical compositions. The applications of these proteins and compositions are aimed at treating various diseases, highlighting Sonderegger's commitment to improving healthcare through his work.
Career Highlights
Ivo Sonderegger is currently associated with Molecular Partners AG, a company dedicated to the development of novel therapeutic proteins. His work at Molecular Partners AG has positioned him at the forefront of biopharmaceutical innovations. The patents he has secured not only showcase his technical expertise but also reflect his passion for applying science to create meaningful solutions.
Collaborations
Throughout his career, Sonderegger has collaborated with esteemed colleagues, including Hans Kaspar Binz and Douglas Phillips. These collaborations have fostered a creative environment where innovative ideas can flourish, ultimately leading to the development of groundbreaking technologies.
Conclusion
Ivo Sonderegger's contributions to the field of biochemistry through his patents and collaborative efforts demonstrate the vital role of inventors in advancing science and improving healthcare. His dedication to innovation continues to inspire future generations in the pursuit of knowledge and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile